Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Focus Areas
BioTech
Pharmaceuticals
Medical Devices
About Investor
Clay Thorp is a General Partner at Hatteras Venture Partners. He focuses on early-stage investments in Medical Devices, Pharmaceuticals, BioTech, and Diagnostics. His investments typically range from Seed to Series A stages. Clay is based in the Raleigh-Durham/Southeast US area. His background includes extensive experience in healthcare and biotech sectors.
Previous investments
Myeloid Therapeutics
73M |2023
Ten63 Therapeutics
16M |2023
Rodin Therapeutics
27M |2017
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP